Skip to main content
Glama

screen_counterparties

ANSWERS: "run my list of lenders through the federal record", "screen these LEIs", "which of my counterparties deny more than their applicant mix predicts". PARAM: a list of public LEIs. Returns per-entity observed versus expected FHA denial rates, coverage flags, method version and an evidence manifest hash. Public entity identifiers only: never borrower files, credit data or personal information. Free preview; the full Evidence Brief needs a licence a human buys on the pricing page, and an agent may relay the offer but can never complete a purchase. Screening signals, not findings of misconduct. Historical observation computed from the public CFPB HMDA 2025 record (actions 1,2,3; loan_type 2). Not a prediction about any individual application. Attribution: FinanceRateCalc, CC BY 4.0.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
lei_listYes1-40 public Legal Entity Identifiers (20-character ISO 17442). Hard cap 100; duplicates removed deterministically.
license_keyNoOptional. A Lemon Squeezy license key issued for 'Counterparty Screen' (one-time or quarterly). Only pass it if the user explicitly provided it.
requested_formatNoOptional. 'evidence_brief' requests the full audit artefact (licensed mode).

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description carries the full burden and does so thoroughly: it discloses return fields, data source, computation details, licensing restrictions, and important limitations like 'not a prediction' and 'screening signals, not findings of misconduct'. It even tells agents they can relay a purchase offer but cannot complete a purchase.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with example queries and packs many important constraints into a compact paragraph. It is slightly dense and mixes legal/methodological caveats with operational guidance, but every sentence earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given that there is no output schema and no annotations, the description is unusually complete: it states input constraints, output items, licensing behavior, data source, and interpretive limits. An agent has enough context to decide whether to call this tool and how to interpret its results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers all parameters at 100%, so the baseline applies. The description adds useful domain context about public identifiers and the licensed Evidence Brief, but it does not meaningfully extend the per-parameter meaning beyond what the schema provides.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly identifies the tool as screening a list of public LEIs against the federal HMDA record and returning observed-versus-expected FHA denial rates. It distinguishes itself from nearby stats tools by framing its purpose as 'which of my counterparties deny more than their applicant mix predicts'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The natural-language examples make it clear when to invoke this tool, and the description gives strong context about acceptable inputs and the licensing boundary for the full Evidence Brief. It does not explicitly name sibling alternatives or state when not to use them, so it stops short of full when-versus-alternative routing.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.